Key result
PGC-1α upregulation reduces obesity-exacerbated myocardial ischemia-reperfusion injury by improving mitochondrial function.
Why the study?
Does PGC-1α upregulation attenuate obesity-exacerbated myocardial ischemia-reperfusion injury and mitochondrial dysfunction in C57BL/6J mice and H9c2 cells?
Does PGC-1α upregulation attenuate obesity-exacerbated myocardial ischemia-reperfusion injury and mitochondrial dysfunction in C57BL/6J mice and H9c2 cells?
Preclinical evidence demonstrates that obesity exacerbates myocardial ischemia-reperfusion injury via PGC-1α downregulation-induced mitochondrial dysfunction, identifying PGC-1α upregulation as a potential therapeutic target.
Answers are grounded in this paper and cite their sources.
Obesity may heighten I/R susceptibility via mitochondrial dysfunction; hypothesis-generating for targeted interventions in clinical cohorts.
Compared to normal individuals, obese individuals demonstrate exacerbated myocardial ischemia-reperfusion (I/R) injury and higher mortality, despite comparable baseline cardiac function. The underlying mechanisms may involve obesity-induced pathophysiological changes-particularly energy metabolism dysregulation and mitochondrial dysfunction-which impair the ability of cardiomyocytes to withstand I/R injury, thereby increasing myocardial susceptibility. Mitochondria, serving as the central hub of energy metabolism, are critically regulated by peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α), a master regulator of mitochondrial biogenesis and metabolic homeostasis. However, the role of PGC-1α in the increased susceptibility of obese myocardium to I/R injury remains unclear. Therefore, this study aims to investigate the mechanisms through which obesity exacerbates myocardial vulnerability to I/R injury, with a specific focus on the role of PGC-1α and mitochondrial dysfunction, to facilitate the development of innovative therapeutic strategies for mitigating I/R injury and improving clinical outcomes in obese patients. C57BL/6J mice were fed a high-fat diet (HFD) for 25 consecutive weeks to establish an obesity model, while control mice received a normal chow diet (NCD). After dietary intervention, control and obese subgroups underwent I/R surgery. In vitro, H9c2 cells were treated with palmitic acid (PA) for 12 h in the presence or absence of PGC-1α overexpression, followed by anoxia/reoxygenation (A/R). Pre-I/R or A/R, cardiac function and cell viability showed no significant differences between obese and control groups. Post-I/R or A/R, the obese group demonstrated markedly worsened cardiac function, enlarged infarct size and reduced cell survival. This was accompanied by elevated mitochondrial and total reactive oxygen species (ROS) production, impaired antioxidant capacity (reduced superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) activity, increased malondialdehyde (MDA)), loss of mitochondrial membrane potential and enhanced mitochondrial permeability transition pore (mPTP) opening-collectively indicating obesity significantly exacerbates I/R injury. Additionally, obese myocardium exhibited downregulated PGC-1α expression, reduced protein levels of nuclear respiratory factor 1 (NRF1) and mitochondrial transcription factor A (TFAM), abnormal mitochondrial dynamics (decreased mitofusin 2 (MFN2), increased dynamin-related protein 1 (DRP1)) and reduced adenosine triphosphate (ATP) production. Crucially, PGC-1α upregulation ameliorated mitochondrial dysfunction and thus attenuated I/R injury. These findings demonstrate that obesity exacerbates myocardial I/R injury through a key mechanism involving PGC-1α downregulation-induced mitochondrial dysfunction, which ultimately enhances cardiac susceptibility to I/R damage.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2026) studied Obesity-exacerbated myocardial ischemia-reperfusion (I/R) injury. PGC-1α upregulation / overexpression and high-fat diet (25 weeks) / palmitic acid treatment (12 h) vs. Normal chow diet (in vivo) and absence of PGC-1α overexpression / control (in vitro) was evaluated on Myocardial ischemia-reperfusion injury (cardiac function, infarct size, cell survival) and mitochondrial dysfunction (ROS production, antioxidant capacity, membrane potential, mPTP opening, mitochondrial dynamics, and ATP production). PGC-1α upregulation ameliorated mitochondrial dysfunction and attenuated obesity-exacerbated myocardial ischemia-reperfusion injury in high-fat diet mice (25 weeks) and H9c2 cells (12 h).
Synapse has enriched 10 related papers. Consider them for comparative context: